Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,267 | -208 | -706 | -541 | -7,891 |
| Depreciation Amortization | 975 | 464 | 329 | 84 | 996 |
| Income taxes - deferred | -365 | 0 | -1 | -4 | 173 |
| Accounts receivable | 468 | 857 | 5 | 55 | 587 |
| Accounts payable and accrued liabilities | 286 | 46 | 112 | 75 | -857 |
| Other Working Capital | 528 | 691 | -12 | 34 | 566 |
| Other Operating Activity | 941 | -589 | 38 | 217 | 1,404 |
| Operating Cash Flow | $565 | $1,260 | $-236 | $-81 | $-5,022 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 331 | 359 | N/A | 244 | N/A |
| PPE Investments | -211 | 4 | 4 | 4 | 43 |
| Net Acquisitions | N/A | N/A | 308 | N/A | 2,678 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | 170 |
| Other Investing Activity | -195 | 10 | 0 | 0 | 1,778 |
| Investing Cash Flow | $-75 | $373 | $313 | $249 | $4,669 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 224 | 192 | N/A | N/A | N/A |
| Debt Repayment | -197 | -197 | -25 | 9 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | -626 |
| Financing Cash Flow | $28 | $-5 | $-25 | $9 | $-626 |
| Exchange Rate Effect | -16 | -82 | -3 | -20 | -41 |
| Beginning Cash Position | 563 | 563 | 563 | 563 | 1,583 |
| End Cash Position | 1,064 | 2,108 | 611 | 719 | 563 |
| Net Cash Flow | $502 | $1,545 | $48 | $157 | $-1,020 |
| Free Cash Flow | |||||
| Operating Cash Flow | 565 | 1,260 | -236 | -81 | -5,022 |
| Capital Expenditure | -326 | N/A | N/A | N/A | -6 |
| Free Cash Flow | 239 | 1,260 | -236 | -81 | -5,028 |